2000
DOI: 10.1159/000020653
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous Inhibition of Renal Phospholipase A<sub>2</sub> and Glutathione Synthesis by Manoalide and <i>DL</i>-Buthionine Sulfoximine Induces Acute Tubular Dysfunction in Rats

Abstract: We have previously demonstrated that gentamicin-induced acute renal failure is mediated by the consumption of renal glutathione (GSH) and accumulation of oxidized phospholipids in tubular epithelial cells as a result of inhibition of phospholipase A2 (PLA2) activity. Based on these results, we tested the hypothesis that the simultaneous inhibition of PLA2 and GSH synthesis induces acute renal failure similar in characteristics to gentamicin-induced acute renal failure. Male Spr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 18 publications
0
6
0
Order By: Relevance
“…Thus, we need to examine whether ROS acts as a key modulator in hypoxia-mediated EPO production in vivo. BSO employed in this experiment has been proven to inhibit glutamyl-cysteine synthetase, a rate-limiting step enzyme of GSH synthesis, resulting in the reduction of GSH contents in various tissues such as liver, lung, and kidney (Griffith and Meister, 1979;Kramer et al, 1985;Soejima et al, 2000). Because GSH acts to scavenge ROS as well as to regenerate other antioxidants, BSO treatment might lead the changes in cellular redox balance (Ganafa et al, 2002).…”
Section: Discussionmentioning
confidence: 98%
“…Thus, we need to examine whether ROS acts as a key modulator in hypoxia-mediated EPO production in vivo. BSO employed in this experiment has been proven to inhibit glutamyl-cysteine synthetase, a rate-limiting step enzyme of GSH synthesis, resulting in the reduction of GSH contents in various tissues such as liver, lung, and kidney (Griffith and Meister, 1979;Kramer et al, 1985;Soejima et al, 2000). Because GSH acts to scavenge ROS as well as to regenerate other antioxidants, BSO treatment might lead the changes in cellular redox balance (Ganafa et al, 2002).…”
Section: Discussionmentioning
confidence: 98%
“…Treatment with cefquinome improve the antioxidant levels as according to ( Soejima et al, 2000 ). Cephalosporins reduce hepatic oxidative damage, as they are thioether having free radical scavenging properties by preventing the free radical-mediated oxidation of sulfhydryl group.…”
Section: Discussionmentioning
confidence: 99%
“…Cefquinome is resistant to inactivation by β-lactamases due to addition of a methoxyimino-aminothiazolyl moiety into the acyl side chain which improve its antimicrobial potency and extensive antibacterial spectrum ( Marshall and Blair, 1999 , Neu, 1982 ). Fourth generation has free radical scavenging potential and good stability against enzymatic hydrolysis ( Soejima et al, 2000 ). Cephalosporins protect against hypochlorous acid (HOCl) oxidative damage.…”
Section: Introductionmentioning
confidence: 99%
“…The treatment with CFPM alone insignificantly affected the hepatic MDA level, SOD, CAT activities and GSH level, although treatment with cefepime in E.coli +CFPM group induced a significant reduction in the hepatic MDA, whilst hepatic SOD, CAT, and GSH were significantly increased PT. According to Soejima et al [44] cephalosporins as cefepime are thioether had free radical scavenging potential and effective in preventing the free radical-mediated oxidation of sulfhydryl group resulted in reduce hepatic oxidative damage.…”
Section: Discussionmentioning
confidence: 99%